Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1521) 1521
Patent (45) 45
Conference Proceeding (25) 25
Book Chapter (17) 17
Newsletter (7) 7
Publication (3) 3
Dissertation (2) 2
Magazine Article (2) 2
Book / eBook (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (986) 986
life sciences & biomedicine (854) 854
humans (839) 839
male (512) 512
infectious diseases (501) 501
female (474) 474
adult (469) 469
hiv infections - drug therapy (355) 355
biological and medical sciences (335) 335
middle aged (317) 317
medical sciences (312) 312
virology (309) 309
immunology (249) 249
microbiology (232) 232
aids/hiv (221) 221
hiv infections - virology (221) 221
viral diseases (214) 214
hiv (210) 210
antiviral agents (199) 199
human viral diseases (192) 192
pharmacology & pharmacy (180) 180
pharmacology. drug treatments (178) 178
viral diseases of the lymphoid tissue and the blood. aids (177) 177
hiv-1 - drug effects (172) 172
anti-hiv agents - therapeutic use (166) 166
antibiotics. antiinfectious agents. antiparasitic agents (165) 165
human immunodeficiency virus--hiv (155) 155
hiv-1 - genetics (153) 153
viral load (153) 153
cd4 lymphocyte count (132) 132
hiv infection (121) 121
chemistry (114) 114
hiv infections - immunology (114) 114
treatment outcome (113) 113
drug therapy, combination (112) 112
hiv-1 (101) 101
antiretroviral drugs (100) 100
psychiatry (99) 99
anti-hiv agents - pharmacology (98) 98
drug therapy (98) 98
immunopathology (98) 98
mutation (98) 98
immunodeficiencies (96) 96
immunodeficiencies. immunoglobulinopathies (96) 96
hiv infections - complications (95) 95
research (89) 89
fundamental and applied biological sciences. psychology (86) 86
physical sciences (86) 86
antiretroviral therapy, highly active (85) 85
genotype (83) 83
health aspects (83) 83
aids (82) 82
analysis (82) 82
anti-hiv agents - administration & dosage (82) 82
prospective studies (82) 82
aged (80) 80
risk factors (80) 80
hiv-1 - physiology (78) 78
rna, viral - blood (75) 75
medicine, general & internal (72) 72
general & internal medicine (70) 70
young adult (68) 68
schizophrenia (66) 66
medicine (65) 65
hiv-1 - isolation & purification (64) 64
patients (63) 63
time factors (63) 63
human immunodeficiency virus (62) 62
retrospective studies (62) 62
hiv protease inhibitors - therapeutic use (61) 61
abridged index medicus (60) 60
adolescent (59) 59
anti-hiv agents - adverse effects (59) 59
drug resistance (59) 59
miscellaneous (59) 59
science & technology - other topics (59) 59
antiretroviral therapy (57) 57
cohort studies (57) 57
highly active antiretroviral therapy (57) 57
magnetic resonance imaging (57) 57
drug resistance, viral (55) 55
multidisciplinary sciences (55) 55
care and treatment (54) 54
viruses (53) 53
neurosciences & neurology (52) 52
clinical trials (51) 51
reverse transcriptase inhibitors - therapeutic use (51) 51
molecular sequence data (50) 50
research article (50) 50
cross-sectional studies (49) 49
infections (49) 49
medicin och hälsovetenskap (48) 48
neurosciences (48) 48
virus diseases (48) 48
drug resistance, viral - genetics (47) 47
medical research (47) 47
acquired immune deficiency syndrome--aids (46) 46
drug administration schedule (46) 46
hiv infections - epidemiology (46) 46
hiv patients (46) 46
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1443) 1443
Spanish (162) 162
French (40) 40
German (11) 11
Portuguese (8) 8
Chinese (3) 3
Norwegian (3) 3
Catalan (1) 1
Indonesian (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials
by Clotet, Bonaventura, Dr and Bellos, Nicholas, MD and Molina, Jean-Michel, MD and Cooper, David, MD and Goffard, Jean-Christophe, MD and Lazzarin, Adriano, MD and Wöhrmann, Andrej, MD and Katlama, Christine, Prof and Wilkin, Timothy, MD and Haubrich, Richard, Prof and Cohen, Calvin, MD and Farthing, Charles, MD and Jayaweera, Dushyantha, MD and Markowitz, Martin, MD and Ruane, Peter, MD and Spinosa-Guzman, Sabrina, MD and Lefebvre, Eric, MD and on behalf of the POWER 1 and 2 study groups and POWER 1 2 Study Grp and POWER 1 and 2 study groups
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 369, Issue 9568, pp. 1169 - 1178
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | HIV Protease Inhibitors - adverse effects | HIV-1 | Darunavir | Drug Administration Schedule | Ritonavir - administration & dosage | Humans | Middle Aged | Male | RNA, Viral - blood | HIV Protease Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Viral Load | Ritonavir - adverse effects | Sulfonamides - therapeutic use | Ritonavir - therapeutic use | Sulfonamides - adverse effects | Adult | Female | HIV Infections - drug therapy | Drug Therapy, Combination | RNA, Viral - drug effects | Sulfonamides - administration & dosage | Usage | Ritonavir | Dosage and administration | Drug therapy, Combination | Drug therapy | HIV infection | Methods | Studies | Antiretroviral drugs | Protease inhibitors | Human immunodeficiency virus--HIV | Mutation | Drug resistance | Patients | Regulatory approval | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713
by Castellví, Marc and Felip, Eudald and Ezeonwumelu, Ifeanyi Jude and Badia, Roger and Garcia-Vidal, Edurne and Pujantell, Maria and Gutiérrez-Chamorro, Lucía and Teruel, Iris and Martínez-Cardús, Anna and Clotet, Bonaventura and Riveira-Muñoz, Eva and Margelí, Mireia and Esté, José A and Ballana, Ester
Cancers, ISSN 2072-6694, 06/2020, Volume 12, Issue 7, p. 1728
n/a
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
by Martin S. Hirsch and Huldrych F. Günthard and Jonathan M. Schapiro and Françoise Brun-Vézinet and Bonaventura Clotet and Scott M. Hammer and Victoria A. Johnson and Daniel R. Kuritzkes and John W. Mellors and Deenan Pillay and Patrick G. Yeni and Donna M. Jacobsen and Douglas D. Richman
Clinical infectious diseases, ISSN 1058-4838, 7/2008, Volume 47, Issue 2, pp. 266 - 285
HIV/AIDS | Antiretrovirals | HIV | Antivirals | Viruses | AIDS | Infections | Drug resistance | Genetic mutation | HIV 1 | Virology | Antiviral agents | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Anti-HIV Agents - pharmacology | Tropism | HIV-1 - drug effects | HIV Infections - epidemiology | Human Immunodeficiency Virus Proteins - drug effects | Humans | Reverse Transcriptase Inhibitors - pharmacology | Integrase Inhibitors - pharmacology | HIV Fusion Inhibitors - pharmacology | HIV-1 - genetics | Drug Resistance, Viral - physiology | Pregnancy | Protease Inhibitors - pharmacology | HIV-1 - physiology | Treatment Failure | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Human Immunodeficiency Virus Proteins - genetics | Mutation | Microbial Sensitivity Tests - methods | CCR5 Receptor Antagonists | Practice guidelines (Medicine) | Drug resistance in microorganisms | Complications and side effects | Reports | HIV infection | Testing | Antiretroviral drugs | Pharmacology | Drug therapy | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
by J Buzón, Maria and Massanella, Marta and Llibre, Josep M and Esteve, Anna and Dahl, Viktor and Puertas, Maria C and Gatell, Josep M and Domingo, Pere and Paredes, Roger and Sharkey, Mark and Palmer, Sarah and Stevenson, Mario and Clotet, Bonaventura and Blanco, Juli and Martinez-Picado, Javier
Nature medicine, ISSN 1078-8956, 04/2010, Volume 16, Issue 4, pp. 460 - 465
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | HIV Integrase Inhibitors - pharmacology | Virus Replication - drug effects | HIV-1 - drug effects | HIV Infections - virology | Humans | DNA, Complementary - genetics | Pyrrolidinones - therapeutic use | HIV Long Terminal Repeat - genetics | Antiretroviral Therapy, Highly Active | HIV Infections - immunology | HIV-1 - immunology | HIV-1 - physiology | Pyrrolidinones - pharmacology | Virus Integration - drug effects | HIV Integrase Inhibitors - therapeutic use | Polymerase Chain Reaction | HIV Infections - drug therapy | DNA, Viral - genetics | HIV Long Terminal Repeat - drug effects | Raltegravir Potassium | Virus Replication - physiology | Highly active antiretroviral therapy | Dosage and administration | Research | Drug therapy | HIV infection | Health aspects | Raltegravir | Immunology | Inhibitor drugs | Antiviral drugs | Human immunodeficiency virus--HIV | Deoxyribonucleic acid--DNA | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort
by Llibre, JM and Montoliu, A and Miró, JM and Domingo, P and Riera, M and Tiraboschi, J and Curran, A and Homar, F and Ambrosioni, J and Abdulghani, N and Force, L and Peraire, J and Casabona, J and Vilaró, Joaquim and Masabeu, Angels and Orti, Amat J and Dalmau, David and Reyes, Juliana and Bruguera, Andreu and Montoliu, Alexandra and Muntada, Esteve and Podzamczer, D and Navarro, G and Cortés, C and Falcó, V and Mallolas, J and Manzardo, C and Imaz, A and Burgos, J and Gracia Mateo, M and Gutierrez, M. M and Murillas, J and Segura, F and García‐Gasalla, M and Puig, T and Vidal, F and Leon, E and Jaen, À and Almuedo, A and De Lazzari, E and Giralt, D and Martin, M and Gargoulas, F and Vanrell, T and Rubia, J. C and Vilà, J and Ferrés, M and Morell, B and Tamayo, M and Laguno, M and Martínez, M and Blanco, J. L and Garcia‐Alcaide, F and Martínez, E and Jou, A and Clotet, B and Saumoy, M and Silva, A and Prieto, P and Navarro, J and Ribera, Esteve and Gurgui, M and Ribas, M. A and Campins, A. A and Fanjul, F. J and Leyes, M and Peñaranda, M and Martin, L and Vilchez, H and Calzado, S and Cervantes, M and Amengual, J and Navarro, M and Payeras, T and Cifuentes, C and Comella, T and Vargas, M and Viladés, C and Barrufet, P and Chivite, I and Chamarro, E and Escrig, C and Cairó, M and Martinez‐Lacasa, X and Font, R and Deig, E and Meyer, S and Hernandez, J and PISCIS Cohort Grp and PISCIS Cohort group
HIV medicine, ISSN 1464-2662, 03/2019, Volume 20, Issue 3, pp. 237 - 247
raltegravir | integrase strand transfer inhibitors | adverse events | dolutegravir | neuropsychiatric toxicity | elvitegravir/cobicistat | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Raltegravir Potassium - adverse effects | Prospective Studies | Humans | Middle Aged | Proportional Hazards Models | Raltegravir Potassium - administration & dosage | Cobicistat - administration & dosage | Male | CD4 Lymphocyte Count | Spain | HIV Infections - immunology | Quinolones - administration & dosage | Quinolones - adverse effects | Heterocyclic Compounds, 3-Ring - administration & dosage | Heterocyclic Compounds, 3-Ring - adverse effects | Adult | Cobicistat - adverse effects | Female | HIV Infections - drug therapy | Medicine, Experimental | Antiviral agents | Complications and side effects | Medical research | RNA | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Observational hertzsprung-russell diagrams
by Barstow, M.A and Jordi, C and Bossini, D and Bressan, A and De Bruijne, J.H.J and Randich, S and Soubiran, C and Walton, N.A and Arenou, F and Lattanzi, M.G and Masana, E and Messineo, R and Panuzzo, P and Portell, J and Tanga, P and Thévenin, F and Burgess, P and Busso, G and Clementini, G and Dell'Oro, A and Fouesneau, M and Frémat, Y and Hambly, N.C and Jean-Antoine-Piccolo, A and Petit, J.-M and Robin, A.C and Sarro, L.M and Smith, M and Sozzetti, A and Anderson, R.I and Antiche, E and Arcay, B and Astraatmadja, T.L and Barache, C and Barata, C and Barros, M and Bertone, S and Blanco-Cuaresma, S and Burlacu, A and Castellani, M and Cowell, S and Crowley, C and De Laverny, P and De Souza, R and De Torres, A and Delgado, H.E and Diener, C and Dolding, C and Durán, J and Fabre, C and Faigler, S and Farràs Casas, M and Federici, L and Garralda, N and Gavel, A and Gavras, P and Geyer, R and Giuffrida, G and Gueguen, A and Gutiérrez-Sánchez, R and Hypki, A and Jonker, P.G and Juhász, Á.L and Julbe, F and Karampelas, A and Kontizas, E and Lanza, A.F and Le Fustec, Y and Licata, E and López, M and Mann, R.G and Mantelet, G and Mary, N and Molina, D and Mor, R and Morbidelli, R and Muraveva, T and Noval, L and Osborne, P and Panahi, A and Plum, G and Ramos-Lerate, M and Riva, A and Rixon, G and Roegiers, T and Royer, F and Sagristà Sellés, T and Salguero, E and Santana-Ros, T and Schultheis, M and Siltala, L and Silva, A.F and Souchay, J and Szegedi-Elek, E and Tapiador, D and Torra Clotet, F and Ulla, A and Voss, H and Wertz, O and Zorec, J and Gaia Collaboration and GAIA Collaboration
Astronomy and astrophysics (Berlin), ISSN 0004-6361, 2018, Volume 616
Stars: evolution | Hertzsprung-Russell and C-M diagrams | Parallaxes | Solar neighborhood | Physical Sciences | Astronomy & Astrophysics | Science & Technology | Fysik | Astronomi, astrofysik och kosmologi | Naturvetenskap | Natural Sciences | Astronomy, Astrophysics and Cosmology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Cognitive reserve as an outcome predictor: first‐episode affective versus non‐affective psychosis
by Amoretti, S and Cabrera, B and Torrent, C and Mezquida, G and Lobo, A and González‐Pinto, A and Parellada, M and Corripio, I and Vieta, E and Serna, E and Butjosa, A and Contreras, F and Sarró, S and Penadés, R and Sánchez‐Torres, A. M and Cuesta, M and Bernardo, M and Bioque, M and Meseguer, A and García, S and Fernández, J and Barcones, F and De‐la‐Cámara, C and Sanjuan, J and Aguilar, EJ and Garnier, PC and Morro, L and Montejo, L and Gomes da Costa, S and Baeza, I and Castro‐Fornieles, J and Menchon, JM and Baenas, I and García‐Portilla, MP and Gutiérrez, M and Segarra, R and Morales‐Muñoz, I and Rodriguez‐Jimenez, R and Usall, J and Pardo, M and Pomarol‐Clotet, E and Landin‐Romero, R and Ibánez, A and Lorente‐Omeñaca, R and Balanzá‐Martínez, V and PEPsGrp and PEPsGroup
Acta psychiatrica Scandinavica, ISSN 0001-690X, 11/2018, Volume 138, Issue 5, pp. 441 - 455
neuropsychology | first episode | cognition | cognitive remediation | cognitive reserve | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Medicine, Experimental | Medical research | Cognitive therapy | Cognition | Mental illness | Analysis | Psychosis | Mental disorders | Memory | Socio-economic aspects | Cognitive ability | Diagnosis | Rehabilitation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
by Eron, Joseph J, Prof and Cooper, David A, Prof and Steigbigel, Roy T, Prof and Clotet, Bonaventura, MD and Gatell, Jose M, Prof and Kumar, Princy N, Prof and Rockstroh, Jurgen K, Prof and Schechter, Mauro, Prof and Markowitz, Martin, Prof and Yeni, Patrick, MD and Loutfy, Mona R, MD and Lazzarin, Adriano, Prof and Lennox, Jeffrey L, Prof and Strohmaier, Kim M, BS and Wan, Hong, MS and Barnard, Richard JO, PhD and Nguyen, Bach-Yen T, MD and Teppler, Hedy, MD and for the BENCHMRK Study Teams and BENCHMRK Study Teams
The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 7, pp. 587 - 596
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Antiviral agents | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Salvage Therapy - adverse effects | Pyrrolidinones - adverse effects | Double-Blind Method | Anti-HIV Agents - adverse effects | HIV Infections - virology | Humans | Middle Aged | Male | Treatment Outcome | CD4 Lymphocyte Count | Viral Load | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Anti-HIV Agents - administration & dosage | Pyrrolidinones - administration & dosage | HIV Infections - immunology | HIV-1 - isolation & purification | Placebos - adverse effects | Adult | Female | HIV Infections - drug therapy | Raltegravir Potassium | Placebos - administration & dosage | Salvage Therapy - methods | Clinical trials | Research | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights